Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSZ04
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,042
Award facts
- Contract value 100% obligated
- $82,041.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $82,041.50 by the Defense Logistics Agency on July 29, 2025, for the supply of Keytruda 100 mg/4 mL vials. The contract utilizes a firm fixed-price structure with an ultimate completion date of August 19, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
Keytruda, an oncology immunotherapy medication, represents part of DMS Pharmaceutical Group's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables supplied to Department of Defense healthcare systems. The company's consistent track record of pharmaceutical deliveries to federal agencies, combined with its woman-owned small business status, has established it as a critical supplier within the federal pharmaceutical supply chain, enabling direct distribution of specialty medications and pharmacy services to military medical facilities globally.
Quick answers
Who was awarded contract SPE2DB25FSZ04?
SPE2DB25FSZ04 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FSZ04 worth?
The government has obligated $82,042 on SPE2DB25FSZ04.
Is contract SPE2DB25FSZ04 an order under another contract?
Yes. SPE2DB25FSZ04 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ04 competed?
The extent of competition for SPE2DB25FSZ04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award